ATRC - AtriCure, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
17.60
+0.01 (+0.06%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close17.59
Open17.58
Bid15.15 x 100
Ask18.60 x 2100
Day's Range17.44 - 17.83
52 Week Range14.78 - 25.18
Volume142,172
Avg. Volume177,151
Market Cap606.744M
Beta-0.02
PE Ratio (TTM)N/A
EPS (TTM)-1.02
Earnings DateFeb 26, 2018 - Mar 2, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.43
Trade prices are not sourced from all markets
  • Business Wire12 days ago

    AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced preliminary financial results for the fourth quarter and full year 2017 and provided 2018 financial guidance.

  • GlobeNewswire12 days ago

    Factors of Influence in 2018, Key Indicators and Opportunity within Insys Therapeutics, LGI Homes, Steelcase, AtriCure, Alliance Holdings GP, and Digital Turbine — New Research Emphasizes Economic Growth

    NEW YORK, Jan. 08, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Insys ...

  • Business Wirelast month

    AtriCure to Present at the 36th Annual JP Morgan Healthcare Conference

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the 36th Annual JP Morgan Healthcare Conference at the Westin St.

  • Capital Cubelast month

    ETFs with exposure to AtriCure, Inc. : December 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to AtriCure, Inc. : December 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to AtriCure, Inc. : November 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Business Wire2 months ago

    AtriCure to Present at the Piper Jaffray 29th Annual Healthcare Conference

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Piper Jaffray 29th Annual Healthcare Conference at the Palace Hotel in New York on Tuesday, November 28, 2017.

  • Capital Cube2 months ago

    ETFs with exposure to AtriCure, Inc. : November 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • AtriCure, Inc. :ATRC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
    Capital Cube2 months ago

    AtriCure, Inc. :ATRC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017

    Categories: Yahoo FinanceGet free summary analysis AtriCure, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of AtriCure, Inc. – Teleflex Incorporated, Edwards Lifesciences Corporation, Boston Scientific Corporation, ABIOMED, Inc. and Johnson & Johnson (TFX-US, EW-US, BSX-US, ABMD-US and JNJ-US) that have also reported for this ... Read more (Read more...)

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of ATRC earnings conference call or presentation 1-Nov-17 8:30pm GMT

    Q3 2017 AtriCure Inc Earnings Call

  • Associated Press3 months ago

    AtriCure reports 3Q loss

    On a per-share basis, the Mason, Ohio-based company said it had a loss of 22 cents. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...

  • Business Wire3 months ago

    AtriCure Reports Third Quarter 2017 Financial Results

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced third quarter 2017 financial results.

  • Capital Cube3 months ago

    AtriCure, Inc. – Value Analysis (NASDAQ:ATRC) : October 26, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives AtriCure, Inc. a score of 25. Our analysis is based on comparing AtriCure, Inc. with the following peers – Teleflex Incorporated, Cooper Companies, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, ABIOMED, Inc., Dextera Surgical, Inc., Stereotaxis, Inc., Medtronic plc and Johnson & Johnson (TFX-US, COO-US, EW-US, BSX-US, ... Read more (Read more...)

  • AtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : October 25, 2017
    Capital Cube3 months ago

    AtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : October 25, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AtriCure, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Business Wire3 months ago

    AtriCure to Present at the Stifel Healthcare Conference

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Stifel Healthcare Conference at the Palace Hotel in New York on Tuesday, November 14, 2017.

  • Business Wire3 months ago

    Mike Hooven, Founder of AtriCure (NASDAQ: ATRC) and Enable Injections, Joins Genetesis Board of Directors

    Genetesis, a medical technology company that gives doctors an accurate, non-invasive tool for seeing how the heart beats, announces the addition of Mike Hooven to its Board of Directors.

  • Business Wire3 months ago

    AtriCure to Announce Third Quarter 2017 Financial Results

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced that it will release its third quarter 2017 financial results on Wednesday, November 1, 2017.

  • AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : September 28, 2017
    Capital Cube4 months ago

    AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : September 28, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AtriCure, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Business Wire4 months ago

    AtriCure Announces U.S. Launch of the AtriClip® PRO•V™ Device

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced that it has launched the AtriClip PRO•V™ Left Atrial Appendage Exclusion System in the United States.

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of ATRC earnings conference call or presentation 27-Jul-17 8:30pm GMT

    Q2 2017 AtriCure Inc Earnings Call

  • Business Wire5 months ago

    AtriCure to Present at the Morgan Stanley Global Healthcare Conference

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York on Tuesday, September 12, 2017.

  • Capital Cube5 months ago

    ETFs with exposure to AtriCure, Inc. : August 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : August 15, 2017
    Capital Cube5 months ago

    AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : August 15, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AtriCure, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • AtriCure, Inc. :ATRC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017
    Capital Cube6 months ago

    AtriCure, Inc. :ATRC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis AtriCure, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of AtriCure, Inc. – Edwards Lifesciences Corporation, Boston Scientific Corporation, ABIOMED, Inc. and Johnson & Johnson (EW-US, BSX-US, ABMD-US and JNJ-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)